(2023)
Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
PLOS ONE.
18,
11
(2023)
Mortality rate and causes of death in papillary thyroid microcarcinoma.
ENDOCRINE.
-,
-
(2023)
Preoperative identification of low‑risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.
SCIENTIFIC REPORTS.
13,
1
(2023)
Thyroid Cancer, Iodine, and Gene Mutation.
International Journal of Thyroidology.
16,
1
(2023)
Association between urinary iodine concentration and the risk of papillary thyroid cancer by sex and age: a case–control study.
SCIENTIFIC REPORTS.
13,
1
(2023)
Dyslipidemia Is a Risk Factor for Hypothyroidism in Women: A Longitudinal Cohort Study from South Korea.
THYROID.
33,
1
(2022)
Identification of Mutations in the Thyroxine-Binding Globulin (TBG) Gene in Patients with TBG Deficiency in Korea.
ENDOCRINOLOGY AND METABOLISM.
37,
6
(2022)
The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy.
EPILEPSIA.
63,
12
(2022)
Graves' disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study.
FRONTIERS IN ENDOCRINOLOGY.
13,
-
(2022)
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients.
ENDOCRINOLOGY AND METABOLISM.
37,
4
(2022)
Bone-density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients on TSH suppression therapy.
CLINICAL ENDOCRINOLOGY.
97,
1
(2022)
What is the difference between the tall cell variant and the classic type of papillary thyroid carcinoma on ultrasonography?.
ULTRASONOGRAPHY.
41,
3
(2022)
Bone Mineral Density Screening Interval and Transition to Osteoporosis in Asian Women.
ENDOCRINOLOGY AND METABOLISM.
37,
3
(2022)
Graves' Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study.
ENDOCRINOLOGY AND METABOLISM.
37,
2
(2022)
Effect of TSH levels during active surveillance of PTMC according to age.
ENDOCRINE-RELATED CANCER.
29,
4
(2021)
Surgeon Volume and Long-Term Oncologic Outcomes in Patients with Medullary Thyroid Carcinoma.
ANNALS OF SURGICAL ONCOLOGY.
28,
13
(2021)
Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer.
CANCERS.
13,
22
(2021)
Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels.
SCIENTIFIC REPORTS.
11,
1
(2021)
Serum Carcinoembryonic Antigen as a Biomarker for Medullary Thyroid Cancer.
International Journal of Thyroidology.
14,
2
(2021)
Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea.
THYROID.
31,
10
단행본
(2016)
임상 내분비학 3판.
도서출판 고려의학.
공동
(2015)
노인병학 제3판.
범문에듀케이션.
공동
(2011)
내분비대사학.
군자출판사.
공동
(2007)
임상심장학.
고려의학.
공동
(2006)
내분비학 용어집.
군자출판사.
공동
(2006)
내분비 대사 증례집.
군자출판사.
공동
(2005)
노인병.
도서출판 의학출판사.
공동
(1999)
당뇨병과 함께 즐거운 인생을.
도서출판 고려의학.
공동
(1999)
내분비학.
고려의학.
공동
(1999)
임상 내분비학 (제2판).
도서출판 고려의학.
공동
(1998)
임상심장학.
고려의학.
공동
특허/프로그램
AHR 분류에 기반한 갑상선암 옣 예측 방법 및 시스템.
10-2017-0097579.
20200219.
대한민국
학술회의논문
(2023)
Clinical manifestations of malignant struma ovarii in a tertiary hospital in Korea.
ENDOCRINOLOGY AND METABOLISM.
대한민국
(2023)
Are TERT promoter mutations a poor prognostic factor in ananplastic thyroid carcinoma?.
ENDOCRINOLOGY AND METABOLISM.
대한민국
(2023)
Association between BMI and Brafv600E mutation status may differ by primary tumor size.
45th Annual Meeting of the European Thyroid Association.
이탈리아
(2023)
Can tert promoter mutation be a poor prognostic factor in undifferentiated thyroid carcinoma?.
45th Annual Meeting of the European Thyroid Association.
이탈리아
(2023)
Clinical manifestations of malignant stma ovarii in a tertiary hospital in Korea.
2023 대한갑상선학회 추계학술대회.
대한민국
(2023)
The association between BMI and BRAFV600E mutation status may differ by primary tumor size.
2023년 대한갑상선학회 추계학술대회.
대한민국
(2023)
Change In The Clinicopathological Characteristics And Outcomes Of Pediatric Thyroid Carcinoma In Korea : Focusing On Data From A Teritary Hospital In Korea.
ENDO 2023.
미국
(2023)
Can TERT promoter mutation be a poor prognostic factor in undifferentiated thyroid carcinoma?.
2023년 대한갑상선학회 춘계학술대회 및 연수강좌.
대한민국
(2023)
갑상선암과 요오드, 그리고 유전자 변이.
범산학술상.
대한민국
(2023)
Association between BMI and BRAF mutational status may differ by primary tumor size.
ENDOCRINOLOGY AND METBOLISM.
대한민국
(2020)
Total Thyroidectomy in Operable Medullary Thyroid Cancer.
AOCE-SICEM 2020.
대한민국
(2020)
Breast cancer metastasized to thyroid which was misread as papillary carcinoma.
2020년 제71차 대한내과학회 추계학술대회.
대한민국
(2020)
Thyroid disease and pregnancy: A comprehensive update.
대한내분비학회 제18회 분과전문의 연수강좌.
대한민국
(2020)
Adequate levothyroxine dose for TSH suppression in differentiated thyroid cancer patients after total thyroidectomy.
2020년 대한갑상선학회 추계학술대회.
대한민국
(2020)
Bone meneral density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients with TSH suppression therapy.
2020년 대한갑상선학회 추계학술대회.
대한민국
(2020)
Changes in the levels of thyrotropin binding inhibitory immunoglobulins following total thyroidectomy or radioiodine therapy in patients with refractory Graves' disease.
2020년 대한갑상선학회 추계학술대회.
대한민국
(2020)
Preoperative serum thyroglobulin and its correlation with the burden and extent of differentiated thyroid cancer.
2020년 대한갑상선학회 추계학술대회.
대한민국
(2020)
The incidence of childhood thyroid cancer continues to increase despite a decline in adult thyroid cancer in Korea.
2020년 대한갑상선학회 추계학술대회.
대한민국
